EP1214342A4 - Polynecluotides, polypeptides et anticorps de recepteurs a hormones steroides - Google Patents

Polynecluotides, polypeptides et anticorps de recepteurs a hormones steroides

Info

Publication number
EP1214342A4
EP1214342A4 EP00961622A EP00961622A EP1214342A4 EP 1214342 A4 EP1214342 A4 EP 1214342A4 EP 00961622 A EP00961622 A EP 00961622A EP 00961622 A EP00961622 A EP 00961622A EP 1214342 A4 EP1214342 A4 EP 1214342A4
Authority
EP
European Patent Office
Prior art keywords
polynecluotides
polypeptides
antibodies
steroid hormone
hormone receptors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00961622A
Other languages
German (de)
English (en)
Other versions
EP1214342A1 (fr
Inventor
Jian Ni
Yanggu Shi
Steven M Ruben
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP1214342A1 publication Critical patent/EP1214342A1/fr
Publication of EP1214342A4 publication Critical patent/EP1214342A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gynecology & Obstetrics (AREA)
EP00961622A 1999-09-09 2000-09-07 Polynecluotides, polypeptides et anticorps de recepteurs a hormones steroides Withdrawn EP1214342A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US15293299P 1999-09-09 1999-09-09
US152932P 1999-09-09
US18903200P 2000-03-14 2000-03-14
US189032P 2000-03-14
PCT/US2000/024517 WO2001018049A1 (fr) 1999-09-09 2000-09-07 Polynecluotides, polypeptides et anticorps de recepteurs a hormones steroides

Publications (2)

Publication Number Publication Date
EP1214342A1 EP1214342A1 (fr) 2002-06-19
EP1214342A4 true EP1214342A4 (fr) 2003-02-26

Family

ID=26850009

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00961622A Withdrawn EP1214342A4 (fr) 1999-09-09 2000-09-07 Polynecluotides, polypeptides et anticorps de recepteurs a hormones steroides

Country Status (5)

Country Link
EP (1) EP1214342A4 (fr)
JP (1) JP2003510036A (fr)
AU (1) AU7354600A (fr)
CA (1) CA2384672A1 (fr)
WO (1) WO2001018049A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001296444A1 (en) * 2000-09-29 2002-04-08 Incyte Genomics, Inc. G-protein coupled receptors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457038A (en) * 1988-11-10 1995-10-10 Genetics Institute, Inc. Natural killer stimulatory factor

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 1 July 2000 (2000-07-01), HEATH: "Human DNA sequence from clone RP11-122k13 on chromosome 10", XP002211063, Database accession no. AL360181 *
DATABASE EMBL [online] 13 September 1999 (1999-09-13), NCI-CGAP: "ws86d07.x1", XP002211062, Database accession no. AW009708 *
DATABASE EMBL [online] 28 June 1999 (1999-06-28), NCI-CGAP: "wf89f02.x1", XP002211061, Database accession no. AI744466 *
See also references of WO0118049A1 *

Also Published As

Publication number Publication date
JP2003510036A (ja) 2003-03-18
AU7354600A (en) 2001-04-10
EP1214342A1 (fr) 2002-06-19
WO2001018049A1 (fr) 2001-03-15
CA2384672A1 (fr) 2001-03-15

Similar Documents

Publication Publication Date Title
AU5732101A (en) Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
EE04630B1 (et) Tsentraalse kannabinoidretseptori antagonistide kasutamine ravimi valmistamisel apetentsi reguleerimiseks
ZA9610536B (en) Antagonists of gonadotropin releasing hormone.
DK0802910T3 (da) Estrogenagonister/antagonister
EP1004313A4 (fr) Remede contre la cachexie
EE03925B1 (et) Farmakoloogiliselt aktiivse aine valmistamise meetod
EP1011667A4 (fr) Antagonistes de l'hormone de liberation de la gonadotrophine
EP0901471A4 (fr) Antagonistes de la gonadoliberine
EP1222253A4 (fr) Polynucleotides, polypeptides et anticorps interagissant avec les recepteurs de retinoides
EP0920319A4 (fr) Antagonistes de la gonadoliberine
NO991593L (no) Hormonpreparat bestÕende av en °strogenforbindelse og en progesteronforbindelse
NO20006313D0 (no) Terapeutiske kombinasjoner omfattende en selektiv vstrogenreseptor modulator og paratyroidhormon
EP1214342A4 (fr) Polynecluotides, polypeptides et anticorps de recepteurs a hormones steroides
AU9621598A (en) Luteinising hormone antagonists useful for treatment of estrogen deficiencies, or as a contraceptive
ATE381618T1 (de) Polypeptidhormon phosphatonin
NO20021948L (no) Prevensjonspreparat basert på et progesteron og et östrogen og en fremgangsmåte for fremstilling av dette
AU4742101A (en) Antagonists of gonadotropin releasing hormone
EP1017709A4 (fr) Recepteur hormonal glycoproteique aomf05 couple par proteines g
AU4738101A (en) Antagonists of gonadotropin releasing hormone
GB9927215D0 (en) Hormone receptor expression
AU2001275362A1 (en) Nuclear hormone receptors
WO2001023563A3 (fr) Compositions et methodes therapeutiques utilisant des proteines morphogeniques, des hormones et des recepteurs d'hormones
AU2002213808A1 (en) Method for determining the peptide hormone activities or the steroid hormone activities of a material or substance mixture
AU6029298A (en) Bioartificial hormone releasing device
GB9716865D0 (en) Antagonists of gonadotrophin releasing hormone

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020409

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIN1 Information on inventor provided before grant (corrected)

Inventor name: NI, JIAN

Inventor name: RUBEN, STEVEN, M.

Inventor name: SHI, YANGGU

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 07K 14/47 A, 7C 07K 14/705 B, 7C 12N 5/10 B, 7C 12N 15/63 B, 7C 12N 15/64 B, 7C 07K 14/72 B

A4 Supplementary search report drawn up and despatched

Effective date: 20030110

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20041104